CancerClaims

Bankruptcy Negotiations Heat Up: J&J's Talc Deal Faces Rejection from Holdouts

4 months ago

In a significant twist within the ongoing legal saga surrounding Johnson & Johnson's talc powder products, a group of objectors has risen to prominently challenge the company’s proposed $8.9 billion settlement aimed at resolving claims related to cancer risks associated with its talc products. The objection comes during the company's bankruptcy proceedings, where J&J has sought to establish a trust fund to compensate thousands of claimants alleging health issues linked to talc use.

J&J's $8.2 Billion Talc Settlement Faces Crucial January Assessment

7 months ago

In a pivotal development for Johnson & Johnson, the company’s monumental $8.2 billion settlement over claims related to its talc-based products is set to undergo a significant evaluation in January. This legal maneuver comes on the heels of extensive allegations that J&J’s talcum powder has been linked to cancer, resulting in a slew of lawsuits against the healthcare giant.

Johnson & Johnson's Talc Bankruptcy Case to Remain in Texas, Increasing Chances for Settlement

7 months ago

In a pivotal ruling that could reshape the landscape for thousands of litigants, a Texas bankruptcy judge has decided to keep Johnson & Johnson’s contentious talc bankruptcy case within the state. This decision, seen as a significant victory for the pharmaceutical giant, could boost the likelihood of a resolution for numerous claims alleging that its talcum powder caused cancers, including ovarian cancer.